CARE AND INNOVATE
Making ECMO safe – Improving patient survival.
At iPerf, we are convinced that the risks of permanent disability associated with the use of cardiopulmonary assistance via ECMO are unacceptable, for both patients and healthcare professionals.
iPerf is developing a disruptive solution that will make it possible to prevent these severe and frequent complications, and thus improve the survival of patients receiving such assistance.
iPerf was the brainchild of Professor Pierre Mordant, a thoracic and vascular surgeon, university professor and hospital practitioner at APHP and University Paris-Cité, who was confronted with this problem in the context of lung transplantation:
“I could no longer accept that a patient whose life had just been saved could leave hospital with a severe disability directly linked to the installation of cardiorespiratory assistance for the transplant”. Pr. Pierre Mordant.
The problem was clearly identified in all the centres using ECMO, and the source of these unacceptable risks was known… Pr. Mordant sought to find a solution and filed several patents.
iPerf is developing a new arterial ECMO cannula that allows practitioners to place the patient on cardiorespiratory assistance via ECMO, while eliminating the risk of ischaemia of the lower limb that could lead to the loss of the leg – with a potential benefit on the survival rate.